CSG's €58bn Slovakia Framework Deal Hinges on EU Deadline as Q1 Orders Reach €17bn
24.05.2026 - 03:13:50 | boerse-global.de
The defence contractor CSG finds itself in an unusual position: its order book is swelling, its pipeline is bulging, and a potential €58 billion framework agreement with Slovakia hangs in the balance — yet the share price remains more than 40% below its January peak. The gap between operational momentum and market sentiment has rarely been so wide.
First-quarter numbers released last week provided ample ammunition for the bulls. Revenue rose 13.8% to €1.544 billion, propelled by a 26.5% surge in the Defence Systems segment to €1.251 billion. Operating EBIT came in at €372 million, translating into a margin of 24.1% — comfortably inside management's full-year target range. The order backlog climbed to €17 billion from €15 billion at the end of 2025, while the sales pipeline stood at an additional €27 billion. Net debt meanwhile shrank sharply to €2.228 billion from €3.004 billion at the year-end, offering further evidence of financial discipline.
Yet that strength has been partly obscured by headwinds in the civilian ammunition business. The Ammo+ division saw revenue slump 20.5% to €291 million, and operating profit plunged 68.5% to just €13 million. CSG blamed a weak US market for commercial ammunition, though it also pointed to longer-term opportunities, including an expanded relationship with the FBI and a $635 million contract for the US Army's Future Artillery Complex in Iowa. A new anti-drone round, tested successfully with the Italian army, was introduced in April and could open another growth avenue.
The stock closed Friday at €18.70, down 3.4% on the day but still up 14.1% for the week. That recovery followed a slide triggered in early May by short-seller Hunterbrook Media, which accused CSG of refurbishing old munitions rather than producing new ammunition and questioned transparency around the IPO and shareholder structure. The company rebutted the claims, calling them a selective reading of public information designed to benefit a related short position. Since hitting a low of €15.73 on 4 May, the stock has rebounded nearly 19%.
Should investors sell immediately? Or is it worth buying CSG?
Nevertheless, it remains 44.7% below the January high and trades 14.6% below its 50-day moving average of €21.90. The volatility is consistent with the high-stakes news flow. Analyst conviction, however, is undimmed: the 12-month consensus price target sits at €32.85, with a range of €25 to €42, and all 10 analysts covering the stock rate it a buy. Moody's recently upgraded CSG's secured senior debt from Ba1 to Baa3, while Fitch affirmed its BBB- rating with a stable outlook.
The biggest near-term catalyst — or risk — revolves around the Slovakian framework agreement. CSG's ZVS Holding arm signed a memorandum with the Slovak defence ministry for munitions deliveries worth up to €58 billion. No firm orders have been placed yet, but the deal is structured to benefit from the EU's SAFE programme, which offers loans at 1% interest over 40 years. To unlock those conditions, Slovakia needs at least one additional EU partner. Romania has already declined; Croatia is still considering. The exception allowing a single country to proceed expires at the end of May.
Should a second partner materialise in time, CSG would have a powerful new narrative to offset the short-seller allegations. Without it, the stock may drift until the next scheduled corporate event — the half-year results on 7 August, preceded by a silent period starting 8 July. In the interim, external data such as German GDP (up 0.3% quarter-on-quarter, with exports rising 3.3% but gross fixed investment falling 1.5%), the Dutch business climate on 29 May, and early June PMIs and inflation prints will provide the trading backdrop.
CSG at a turning point? This analysis reveals what investors need to know now.
Technically, the key support level to watch is €18.56. As long as the share holds above that zone, last week's rebound remains intact. A break below would raise questions about the post-earnings stabilisation attempt and could reopen the path towards the May trough. With a €17 billion backlog and a €27 billion pipeline underpinning the business, the fundamentals argue for patience — but the market is demanding proof that the order book can translate into sustained share price gains.
Ad
CSG Stock: New Analysis - 24 May
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
